√Assessment and Management of Antinuclear Antibodies positive population

title: √Assessment and Management of Antinuclear Antibodies positive population
Edition: Original
Classification: Patient version of guideline
Field:
Countries and regions: China
Guidelines users:
Evidence classification method: GRADE
Development unit: Guangdong Provincial Clinical Research Center for Immunological Diseases
Registration time: 2020-09-11
Registration number: IPGRP-2020EN045
Purpose of the guideline: